Abacavir Base (CAS number 188062-50-2) is a powerful drug typically utilized in the management of HIV infection and associated secondary infections . It functions as a reverse transcriptase suppressor, interfering with the HIV's replication process . Administered usually in conjunction other AIDS agents , abacavir has a key part in controlling the amount of virus and improving patient well-being . Careful human leukocyte screening for the B*57:01 allele is essential prior to start of this regimen to reduce the chance of a serious adverse effect.
Abarelix (183552-38-7): Characteristics and Functions
Abarelix, identified by the CAS Registry Number 183552-38-7, is a laboratory-created protein agonist of gonadotropin-releasing hormone (GnRH). This key characteristic lies in its ability to initially stimulate, then rapidly desensitize GnRH receptors, leading to a significant reduction in reproductive production . Therapeutically, abarelix is applied primarily in the therapy of advanced prostate malignancy ; however, studies also explores possible uses in other hormonal imbalances and reproductive wellness . The compound 's structure allows for selective receptor binding .
```text
Abiraterone Acetate (154229-18-2): Synthesis and Analytical Data
The production of Abiraterone Acetate, identified by the Chemical Abstracts Service Registry Number 154229-18-2, involves detailed multistep chemical routes. Several reported methods exist, often beginning with Androstadienedione and utilizing specific oxidation and acetylation steps. A typical process includes protecting group strategies to ensure desired regioselectivity. Analytical data, crucial for purity control, routinely employs liquid chromatography (HPLC) for measurement of content. Nuclear Magnetic Resonance (NMR) examination confirms the structural identity. Mass spectrometry supplies molecular weight verification. Other methods, like infrared (IR) analysis, assist in characterization and are critical for batch release.
- Production Routes
- Quality Control
- Analytical Characterization
```
```text
Understanding the CAS Numbers of Abacavir, Abarelix, and Abiraterone Acetate
Identifying chemical substances accurately is paramount in fields like medicine, research, and manufacturing. A crucial tool for this identification is the Chemical Abstracts Service (CAS) registry number – a unique numerical identifier assigned to every distinct chemical compound. Let's examine the CAS numbers for three significant pharmaceuticals: Abacavir, Abarelix, and Abiraterone Acetate. Understanding these identifiers aids in precise referencing and prevents ambiguity within scientific literature and regulatory documentation. Abacavir, a nucleoside reverse transcriptase inhibitor used to treat HIV, holds the CAS number 60242-78-0. Abarelix, a gonadotropin-releasing hormone (GnRH) receptor here antagonist employed in prostate cancer treatment, is identified by the CAS number 5490-02-9. Finally, Abiraterone a CYP17 inhibitor used in metastatic prostate cancer, possesses the CAS number 857342-50-7. Precisely utilizing these numbers ensures clarity and consistency when discussing these medications.
- Abacavir CAS Number: 60242-78-0
- Compound B CAS Number: 5490-02-9
- Compound C CAS Number: 857342-50-7
```
Essential Facts on Abacavir Salt, Abarelix , and Abiraterone Acetate
These therapies represent distinct treatments in medicine. Abacavir is a nucleoside reverse transcriptase inhibitor primarily used to treat HIV infection , often in combination other medications. Abarelix is a drug that works as a receptor blocker, typically employed to reduce prostate cancer before removal. Lastly, Abiraterone Acetate is another medication given to manage advanced prostate growths, specifically inhibiting testosterone synthesis . Please consult a healthcare professional for complete information and advice regarding any drug.
Medical Insights: Abacavir, Abarelix, Abiraterone Drug and Their CAS Codes
Examining various medicinal agents requires some defined recognition. Specifically, Abacavir Sulfate, utilized in AIDS management, has a CAS Code of 3870-92-6. Similarly, Abarelix, an GnRH inhibitor given for prostate growths care, exhibits the Chemical Abstracts Service Code 64347-82-2. Lastly, Abiraterone Acetate, a compound in metastatic prostate lesions, is known as associated with the Registration Number 864930-63-3. The codes represent vital instruments to precise drug referencing and research.